ClinicalTrials.gg
CompletedNCT07060820Updated Jan 21, 2026

Association Between Radial Artery Access Point and Radial Artery Spasm

An interventional study of Radial Artery Puncture at 0-20 mm and Radial Artery Puncture at >21 mm in Coronary Artery Disease and Radial Artery Spasm, sponsored by Mersin Medicalpark Hastanesi. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-21.

Sponsored by Mersin Medicalpark Hastanesi · Not applicable, Interventional, and Diagnostic

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
380
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 139 studies in Coronary Artery Disease with a site in Turkey — 34 open to participants now, 43 under way, 4 of them phase 3. Coronary Artery Disease · Turkey.

Enrollment
15th of 73
380 · median 70
Started
2025
with 18 others
No phase
60 of 139
18 open now
Registered
97th of 139
by date

Among the 139 studies in Coronary Artery Disease with a site in Turkey, this one is the 15th largest by enrollment of the 73 interventional ones that give a count, is one of 19 that started in 2025, is one of 60 with no phase, and was the 97th registered.

Coronary Artery Disease

4,866 studies on the registry are indexed under Coronary Artery Disease; 892 are open to participants now.

Browse Coronary Artery Disease studies →

Open to participants now

34 of the 139 studies in Coronary Artery Disease with a site in Turkey are open now. Recruiting first, the newest first:

29 more — sign in →

All 34 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 591 Coronary Artery Disease studies recruiting now, 404 (68%) set no upper age limit and 68 (12%) stop at 75 or younger; 37 take children under 18; 49 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 139 studies in Coronary Artery Disease with a site in Turkey, or all of them as a file.
02

Study summary

This prospective clinical study aims to investigate whether the puncture site distance from the radial styloid process affects the incidence of radial artery spasm (RAS) during coronary angiography. Patients undergoing coronary angiography via radial access will be randomized into two groups based on the puncture site distance: 0-20 mm and >21 mm from the styloid process. The procedure will be performed by experienced interventional cardiologists using standard techniques and medications. The primary goal is to determine if a specific puncture site reduces the incidence of RAS, which is a common complication during transradial procedures. The study will also record procedural details and monitor for other complications to identify the optimal puncture site for reducing RAS and improving patient comfort.

Read the detailed description

The transradial approach (TRA) is the standard vascular access route for diagnostic coronary angiography and percutaneous coronary interventions, in accordance with contemporary guidelines, due to lower bleeding risk, improved patient comfort, and facilitation of early mobilization compared with femoral access. Despite these advantages, radial artery spasm (RAS) remains a common and clinically relevant complication during transradial procedures, often associated with procedural difficulty, the need for access site crossover, and patient discomfort.

RAS is characterised by sudden, transient contraction of the radial artery during sheath insertion or catheter manipulation, which may result in difficulty in catheter advancement, and, in rare cases, procedural failure or catheter entrapment. Several clinical and procedural factors have been identified as being associated with the development of RAS, including female sex, smaller arterial diameter, use of larger sheaths, inadequate sedation, and limited operator experience. Currently radial access is recommended near the styloid process but there is limited data on the effects of different puncture distances from the styloid process on the development of RAS. We examined the impact of different radial artery puncture distances from the styloid process, on the development of radial artery spasm and access-site-related complications.

03

Conditions studied

  • Coronary Artery Disease
  • Radial Artery Spasm

Keywords

  • Transradial Access
  • Radial Artery Spasm
  • Coronary Angiography
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Adults aged 18 years and older. Patients scheduled for coronary angiography via transradial access. Patients with a palpable radial artery pulse. Patients with a normal Allen test.

Exclusion criteria

Exclusion Criteria:

Abnormal Allen test results. Absence of palpable radial artery pulse. History of prior transradial coronary angiography with hemodynamic instability. Patients with severe comorbid conditions precluding safe participation in the study.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
380 participants (actual)

Study arms

  • Experimental
    0-20 mm Puncture Distance Group

    Radial artery puncture performed 0-20 mm proximal to the radial styloid process during transradial coronary angiography to evaluate its effect on the incidence of radial artery spasm (RAS).

    Procedure: Radial Artery Puncture at 0-20 mm

  • Experimental
    21 mm Puncture Distance Group

    Radial artery puncture performed 21-40 mm proximal to the radial styloid process during transradial coronary angiography to evaluate its effect on the incidence of radial artery spasm (RAS).

    Procedure: Radial Artery Puncture at >21 mm

Interventions

  • ProcedureRadial Artery Puncture at 0-20 mm

    Radial artery puncture performed 0-20 mm proximal to the radial styloid process during transradial coronary angiography to evaluate its impact on the incidence of radial artery spasm (RAS).

  • ProcedureRadial Artery Puncture at >21 mm

    Radial artery puncture performed at a distance greater than 21 mm proximal to the radial styloid process during transradial coronary angiography to evaluate its impact on the incidence of radial artery spasm (RAS).

06

What researchers measure

Primary outcomes

  1. Radial Artery Spasm during Transradial Coronary Angiography

    İnsidance of Radial Artery Spasm during Transradial Coronary Angiography

    Time frame: During the procedure

Secondary outcomes

  1. Incidence of access site complications

    Number of patients experiencing access site complications including hematoma, bleeding, or occlusion within 5 days after the procedure.

    Time frame: Within 5 days post-procedure

07

Study locations

1 site
  • VM Medicalpark Mersin Hospital
    Mersin, Mezitli 33200, Turkey (Türkiye)
08

References and documents

Publications

  • Aslan V, Sural S, Yeral N, Gorgulu S, Brilakis ES. Effect of the Distance Between the Radial Artery Puncture Site and the Styloid Process on Radial Artery Spasm in Transradial Coronary Interventions: A Randomized Study. Catheter Cardiovasc Interv. 2026 Jul 16. doi: 10.1002/ccd.70754. Online ahead of print. PubMed 42460683 ↗

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared because the study is a single-center observational procedural study with limited resources for external data sharing and monitoring. Data can be shared upon reasonable request to the principal investigator in compliance with local regulations.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2025 to primary completion in Dec 2025, 5 months.

Of 756 non-industry interventional studies with no phase under Coronary Artery Disease, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 53. This study's 5 months is below that.

Counting every sponsor, half of 933 studies reached it within 30 months; a quarter within 15 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 2, 2025
First posted
Jul 11, 2025
StartActual
Jul 3, 2025
Primary completionActual
Dec 31, 2025
CompletionActual
Jan 15, 2026
Last update
Jan 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07060820
Lead sponsor
Mersin Medicalpark Hastanesi
Responsible party
Sponsor
First posted
Jul 11, 2025
Start date
Jul 3, 2025
Primary completion
Dec 31, 2025
Completion
Jan 15, 2026
Last update
Jan 21, 2026

Study contacts

Vedat ASLAN, MD
principal investigator · Toros University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion